- Published at
- by prnewswire.com
mixed
mixed
News for Neovasc Inc. (G5Z3.F)
- Published at
- by benzinga.com
neutralneutralWhy Neovasc's Stock Is Trading Lower Today
Neovasc (NASDAQ: NVCN) shares are trading lower after the company announced a $72 million registered direct offering priced at-the-market. Neovasc Inc is a ...- Published at
- by benzinga.com
mixedmixedMid-Day Market Update: US Stocks Turn Lower; Bio-Path Shares Jump
Midway through trading Wednesday, the Dow traded down 0.07% to 31,355.00 while the NASDAQ fell 0.46% to 13,943.81. The S&P also fell, dropping 0.23% to ...- Published at
- by marketscreener.com
positivepositiveNeovasc Announces US$72 Million Registered Direct Offering Priced At-The-Market
Vancouver, Canada, Feb. 10, 2021 -- via NewMediaWire?--?Neovasc Inc. announced today that it has entered into definitive agreements with certain healthcare-focused institutional... | February 10, 2021- Published at
- by yahoo.com
positivepositiveNeovasc Announces US$72 Million Registered Direct Offering Priced At-The-Market
Vancouver, Canada, Feb. 10, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Neovasc Inc. (“Neovasc” or the “Company”) (Nasdaq: NVCN / TSX: NVCN) announced today that it has entered into definitive agreements with certain healthcare-focused institutional investors for the sale of an aggregate of 36,000,000 common shares at a purchase price of US$2.00 per common share in a registered direct offering (the “Offering”) priced at-the-market under the Nasdaq Capital Market (the- Published at
- by rttnews.com
mixedmixedGMDA On Track, GNFT Soars, HTBX Sparkles, LLY's Neutralizing Antibody Therapies Get FDA Nod
Today's Daily Dose brings you news about KalVista's hereditary angioedema trial results, Heat Biologics' encouraging data from its phase II trial of HS-110 in non-small cell lung cancer, Gamida's presentation of full efficacy and safety results of Omidubicel in patients with hematologic malignancies and Neovasc regaining Nasdaq compliance.- Published at
- by benzinga.com
positivepositiveWhy Neovasc's Stock Is Trading Higher Today
Neovasc (NASDAQ:NCVN) shares are trading higher after the company regained compliance with the Nasdaq minimum bid price rule. Neovasc Inc is a specialty ...- Published at
- by rttnews.com
mixedmixed- Published at
- by marketscreener.com
neutralneutralNeovasc Responds to FDA Not-Approvable Letter Regarding Neovasc Reducer(TM)
?Neovasc Inc. ? ?announced today that it has received a not-approvable letter from U.S. Food & Drug Administration regarding its PMA submission for the Neovasc Reducer™ .Fred... | January 15, 2021- Published at
- by yahoo.com
negativenegativeFINAL DEADLINE IMMINENT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Neovasc Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / January 3, 2021 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Neovasc Inc.